Novo Nordisk announces Maziar Mike Doustdar as new CEO

Novo Nordisk announces Maziar Mike Doustdar as new CEO

Novo Nordisk said Tuesday it was tapping Maziar Mike Doustdar, its head of international operations, as its new CEO, amid a broader leadership shakeup across the company. Novo’s current CEO, Lars Fruergaard Jørgensen, announced he was stepping down in May, as the company faced a tumbling share price and growing competition from Eli Lilly in the…

Read More
Pharma tariffs set at 15% in European Union trade deal

Pharma tariffs set at 15% in European Union trade deal

WASHINGTON — President Trump’s tariffs on pharmaceuticals coming from the European Union will be set at 15% and will not go into effect until a national security investigation has been completed, according to a White House official familiar with the plans.  Once the Section 232 investigation is finished and its associated tariffs are levied, they…

Read More